In the UK alone we estimate our systems have avoided harm and mortality (shown right), as well as money saved on the direct costs of treatment created from avoidable harms.
These figures ignore reductions in other costs, complaint handling and negligence/malpractice related litigation and awards.
C2-Ai have the most robust software approach to comparing safety and quality across hospitals, systems and physicians that I have ever seen. The algorithms are backed up by years of published international research. I believe their approach could be most useful as a solution for providers across any network.
“It took 2 years and a very costly investigation to deal with a competence issue in our organisation some time ago. We set CRAB® the blind challenge of seeing if they could have found the problem in our historical data. They did so in 20 minutes. Needless to say, we have invested in the system”
“CRAB® can identify outcomes that are better than expected, as well as those that are worse, and thus can be used as an improvement tool as well as to assure clinicians and others of the standard of care being provided, and to measure productivity”
“CRAB® predictions have proved accurate in my primary external research validation of the system. I currently don’t know of any other electronic system in use that can deliver this kind of overall and detailed qualitative feedback to the department and the individual surgeon. It has been a great benefit for our clinic and helped develop our work on patient safety.”
“To have reports of this quality dropping on to my iPad is a real joy”
“This exercise is not about making data/surgeons/departments look good, but about being accurate so that performance can truly be assessed”
“CRAB has allowed real time review of data, which has raised awareness and led to change in both clinical practice and hospital culture. I think it will become an essential part of the appraisal and governance structures of secondary care.”
“We use CRAB to provide us with a detailed monthly audit report of each surgeons complications, adjusted against CRABs risk methodology, in order to monitor outcomes performance. Our Clinical Leads meet monthly and review any complications that arise in order to inform and learn from the evidence. We find CRAB provides outcomes intelligence quickly, enabling us to be ‘on top’ of outcomes immediately.
One of the significant gains from using CRAB is a massive improvement in our coding from an engaged clinical workforce”
“CRAB just makes sense. It presents data in a way that is easy to understand and interpret. It has been immensely useful for me both personally in my appraisal and in my role as a Clinical Director. It helps me to pick up early warning of problems with intelligence that can be believed and acted upon”
“CRAB® is 100% better than any solution available to us at the moment. It has turned out to be a very useful tool in analysing and understanding our case-mix and where our complications are occurring.”
“We are thrilled to receive this award, which reflects a great deal of hard work and support from within and […] the support of CRAB® Clinical Informatics (C2-Ai) who enabled us to benchmark our Trust’s AKI rates against national levels – and then measure the significant impact of our AKI Programme, which coincided with a significant and sustained fall in AKI rates our Trust, especially across surgical wards”
The problem with [HSMR systems] is that they tell you there might be a problem, but not where or why. CRAB® tells you exactly what and where the problem is, and even which patients are involved. Then you can do something about it.”
“CRAB has provided data for the consultants to really understand their outcomes for patients in a user friendly way.”
“CRAB is generating trusted data which we can use to flag up areas of concern. From there we are able to take action in a much more sophisticated way than we have in the past.”
“I have worked with C2-Ai for the past seven years, and their insights have shone a light on the quality and safety of patient care that other less sophisticated analyses have not been able to provide”
We receive patient data from 46 countries and operate in 11.